# \[e-drug\] Essential Drugs Monitor subscribing information

**URL:** <https://talk.edrugplus.org/t/e-drug-essential-drugs-monitor-subscribing-information/12584>\
**Category:** e-drug\
**Created:** [October 2, 2001, 11:07am UTC](https://talk.edrugplus.org/t/e-drug-essential-drugs-monitor-subscribing-information/12584 "2001-10-02T11:07:07Z")\
**Posts on this page:** 1\
**Page:** 1

<div class="post-metadata">

**Author:** ![EDM\_Documentation\_Ce](https://avatars.discourse-cdn.com/v4/letter/e/57b2e6/32.png) [@EDM\_Documentation\_Ce](https://talk.edrugplus.org/u/EDM_Documentation_Ce)\
**Post date:** [October 2, 2001, 11:07am UTC](https://talk.edrugplus.org/t/e-drug-essential-drugs-monitor-subscribing-information/12584/1 "2001-10-02T11:07:07Z")

</div>

E-drug: Essential Drugs Monitor subscribing information  
-------------------------------------------------------------------------

[After receiving WHO's Essential Drugs Monitor this morning, I  
thought there might be more E-druggers interested in receiving it. I  
contacted the Editor and she asked me to circulate the subscription  
form (below). The Essential Drugs Monitor is distributed free of  
charge. Which quality journal beats that? HH]

------------------------  
The Essential Drugs Monitor is produced and distributed by the  
World Health Organization Department of Essential Drugs and  
Medicines Policy. It is published in Chinese, English, French,  
Russian and Spanish and is free of charge with a global readership  
of some 250 000. The Monitor carries news of developments in  
national drug policies, therapeutic guidelines, current  
pharmaceutical issues, educational strategies and operational  
research.

If you would like to subscribe to the Monitor please complete the  
form below and return it by e-mail, fax, or snailmail to:

EDM Documentation Centre, Essential Drugs and Medicines Policy,  
World Health Organization, 20 avenue Appia, CH-1211 Geneva 27,  
Switzerland. Tel: + 41 22 791 3521, Fax: + 41 22 791 4167,  
e-mail: edmdoccentre@who.int

:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::  
:::::::::::::::  
I would like to subscribe to the Essential Drugs Monitor and receive  
regular copies in one language free of charge

Name .....................................  
Agency .....................................  
Profession .....................................  
Address .....................................  
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;.....................................  
Country .....................................

Language required (please indicate):  
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0 Chinese  
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0 English  
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0 French  
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0 Russian  
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0 Spanish

--  
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.  
Information and archive [http://satellife.healthnet.org/programs/edrug.html](http://satellife.healthnet.org/programs/edrug.html)  
Mail administrative requests to `majordomo@usa.healthnet.org'.  
For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.
